Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: a large, multicenter, observational study

被引:0
|
作者
Joohyun Woo
Se Jeong Oh
Jeong-Yoon Song
Byung Joo Chae
Jung Eun Choi
Jeeyeon Lee
Heung Kyu Park
Woosung Lim
机构
[1] Ewha Womans University Mokdong Hospital,Department of Surgery
[2] Ewha Womans University College of Medicine,Department of Surgery, College of Medicine
[3] The Catholic University of Korea,Department of Surgery
[4] Kyung Hee University Hospital at Gangdong,Department of Surgery, Division of Breast Surgery, Samsung Medical Center
[5] Sungkyunkwan University School of Medicine,Department of Surgery
[6] Yeungnam University Hospital,Department of Surgery, School of Medicine
[7] Kyungpook National University,Department of Breast Surgery
[8] Gachon university Gil Medical Center,undefined
来源
BMC Cancer | / 21卷
关键词
Breast cancer; Young patients; Neoadjuvant chemotherapy; ER-positive; Pathologic complete response;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Complete Breast MRI Response to Neoadjuvant Chemotherapy and Prediction of Pathologic Complete Response
    Chen, Christina A.
    Hayward, Jessica H.
    Woodard, Genevieve A.
    Ray, Kimberly M.
    Starr, Christopher J.
    Hylton, Nola M.
    Joe, Bonnie N.
    Lee, Amie Y.
    JOURNAL OF BREAST IMAGING, 2019, 1 (03) : 217 - 222
  • [22] Clinical profile and outcome associated with breast cancer recurrence after pathologic complete response to neoadjuvant chemotherapy: A multicenter study
    Asaoka, Mariko
    Ishikawa, Takashi
    Sato, Eiichi
    Narui, Kazutaka
    Chishima, Takashi
    Yamada, Akimitsu
    Suganuma, Nobuyasu
    Kawaguchi, Tsutomu
    Takabe, Kazuaki
    CANCER RESEARCH, 2018, 78 (13)
  • [23] Determining a correlation between certain multimolecular markers and pathologic complete response for ER-positive breast cancer.
    Wang, Kun
    Zhu, Teng
    Zhang, Yi-Fang
    Liu, Chunling
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy
    Hee Jun Choi
    Jai Min Ryu
    Isaac Kim
    Seok Jin Nam
    Seok Won Kim
    Jonghan Yu
    Jeong Eon Lee
    Se Kyung Lee
    Breast Cancer Research and Treatment, 2019, 176 : 591 - 596
  • [25] Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy
    Choi, Hee Jun
    Ryu, Jai Min
    Kim, Isaac
    Nam, Seok Jin
    Kim, Seok Won
    Yu, Jonghan
    Lee, Jeong Eon
    Lee, Se Kyung
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (03) : 591 - 596
  • [26] Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study
    Qian, Bei
    Yang, Jing
    Zhou, Jun
    Hu, Longqing
    Zhang, Shoupeng
    Ren, Min
    Qu, Xincai
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [27] Association of pathologic complete response following neoadjuvant chemotherapy with survival among young women with breast cancer
    Greenup, Rachel Adams
    Bardia, Aditya
    Buckley, Julliette M.
    Niemierko, Andrzej
    Camp, Melissa
    Coopey, Suzanne
    Gadd, Michele
    Schapira, Lidia
    Taghian, Alphonse G.
    Smith, Barbara L.
    Specht, Michelle Connolly
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Endo Predict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancer
    Bertucci, Francois
    Finetti, Pascal
    Viens, Patrice
    Birnbaum, Daniel
    CANCER LETTERS, 2014, 355 (01) : 70 - 75
  • [29] Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer
    Moon, Hyeong-Gon
    Yi, Jae Kyo
    Kim, Hee Sung
    Lee, Hea Young
    Lee, Kyung-Min
    Yi, Minju
    Ahn, Sookyung
    Shin, Hee-Chul
    Ju, Ji-hyun
    Shin, Incheol
    Han, Wonshik
    Noh, Dong-Young
    BMC CANCER, 2012, 12
  • [30] Neoadjuvant endocrine therapy vs chemotherapy for postmenopausal ER-positive breast cancer patients
    Semiglazov, VF
    Ivanov, VG
    Semiglazov, VV
    Ziltsova, EK
    Keltzel, AA
    Melnikova, OA
    Topuzov, EE
    Paltuev, RM
    Bozhok, AA
    Dashian, GA
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S106 - S107